Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
U.S. rejection of Novo drug seen temporary but costly
Yahoo/Reuters
Thu, 02/21/13 - 12:03 pm
Novo Nordisk
Tresiba
diabetes
Takeda Faces First Trial Over Actos Diabetes Drug in L.A.
Bloomberg
Tue, 02/19/13 - 10:11 am
Takeda
Actos
diabetes
Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Yahoo
Tue, 02/19/13 - 09:54 am
lixisenatide
Sanofi
FDA
diabetes
GLP-1 receptor
Takeda Worried About Actos’s Cancer Link, Filing Shows
BusinessWeek
Sat, 02/16/13 - 12:23 pm
type 2 diabetes
Takeda
diabetes
cancer
Actos
Merck's Dynamic Duo
Motley Fool
Fri, 02/15/13 - 10:42 am
Merck
Januvia
Janumet
diabetes
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
Mylan, Biocon help market generic insulin drugs
Yahoo/AP
Thu, 02/14/13 - 10:18 am
Biocon
Mylan
generics
diabetes
insulin
Lantus
Humalog
Novolog
Will Johnson & Johnson Win Approval for Its Diabetes Drug?
Motley Fool
Tue, 02/12/13 - 11:00 am
JNJ
diabetes
Invokana
Novo Nordisk hit hard as U.S. rebuffs insulin drug
Yahoo/Reuters
Mon, 02/11/13 - 08:15 am
insulin
Novo Nordisk
diabetes
FDA
Tresiba
Diabetes: Insulet and Dexcom call it quits on development agreement
Mass Device
Thu, 02/7/13 - 09:26 pm
diabetes
Insulet
DexCom
contract
devices
What Will Type 2 Diabetes Treatments Look Like in 5 Years?
Motley Fool
Wed, 02/6/13 - 08:34 am
diabetes
Merck
SGLT2 inhibitor
Bristol-Myers Squibb
AstraZeneca
JNJ
Array Biopharma
Januvia
Amgen
Forixga
GKAs
Diabetes: GI Dynamics touts positive results in "mildly obese" patients treated with EndoBarrier
Mass Device
Tue, 02/5/13 - 11:09 pm
diabetes
GI Dynamics
patients
EndoBarrier
Alas, Hamlet! A Diabetes Drugmaker to Renew the Faith
Motley Fool
Tue, 02/5/13 - 10:49 am
diabetes
Novo Nordisk
Sanofi's New Diabetes Play Moves Forward
Motley Fool
Tue, 02/5/13 - 10:30 am
Sanofi
diabetes
Lyxumia
GLP-1 agonist
AstraZeneca, Bristol-Myers’s Forxiga Not Backed by NICE
Bloomberg
Fri, 02/1/13 - 10:57 am
AstraZeneca
Forxiga
Bristol-Myers Squibb
UK
diabetes
Diabetes: New, positive data on "artificial pancreas" research | MassDevice.com On Call
Mass Device
Wed, 01/30/13 - 05:52 pm
diabetes
artificial pancreas
research
devices
Transition Therapeutics To Trade Higher Into Upcoming Trial Results For Diabetes Drug
Seeking Alpha
Mon, 01/28/13 - 10:48 am
Transition Therapeutics
diabetes
TT-401
Eli Lilly
Furiex Rises on FDA Approval of Takeda Diabetes Medicine
Bloomberg
Mon, 01/28/13 - 10:47 am
FDA
diabetes
Takeda
Furiex Pharmaceuticals
alogliptin
Takeda Diabetes Drug Succeeding Actos Wins FDA Approval
Bloomberg
Mon, 01/28/13 - 10:11 am
Takeda
diabetes
Actos
FDA
FDA announces approval of three new drugs to treat Type 2 diabetes
examiner.com
Sun, 01/27/13 - 11:35 am
type 2 diabetes
Takeda
diabetes
alogliptin
Furiex Pharmaceuticals
Pages
« first
‹ previous
…
74
75
76
77
78
79
80
81
82
…
next ›
last »